top
Robert Garner: email
I am originally from Starkville, MS. I received my B.S. in chemistry from Jackson State University in May 2006.
My current research is investigating the factors that lead to photoinduced ligand loss in Ru(II) poylpyridyl complexes. I also work to design complexes with low energy absorptions and high quantum yield of ligand loss. My goal is use these complexes as anticancer agents and/or to use the complexes to deliver other anticancer agents to cancerous cells.
top
Scott Burya: email
After obtaining my B.S. in Chemistry from Ohio University in 2007, I joined the Turro group at the Ohio State University.
I completed my Masters thesis on the quenching of luminescent DNA probes by ferrocyanide in Aug. 2009. We concluded that the extent of ferrocyanide quenching depends on the probe's ds-DNA binding constant, not the mode of binding as was previously posited (Burya et al. Chem. Comm. 2011, 47, 1848).
Currently, I am synthesizing and investigating the photo-physical properties of two isomers of Rh2(HNOCCH3)2(CH3CN)6]2+. Irradiation of these complexes with low energy light results in the loss of CH3CN which makes them potential photodynamic therapy agents akin to [Rh2(O2CCH3)2(CH3CN)6]2+ (Turro et al. J. Amer. Chem. Soc. 2006, 128, 738).
top
Mark Sgambellone: email
I received my bachelors in chemistry from Case Western Reserve University in 2007, and am now a 4th year graduate student in the Turro lab at Ohio State. I received my masters degree in 2009, and am continuing to my PhD.
I study light sensitive ruthenium compounds for use in photodyamic therapy. I mostly work with octahedral ruthenium complexes with two or more photo labile acetonitrile or acetonitrile type ligands.
top
Nick Leed: email
I am originally from Lancaster, PA. I received my undergraduate degree from Millersville University in Pennsylvania in December 2003. I went on to work as an analytical chemist at Shank's Extract in Lancaster PA before coming to OSU. Currently I am in my second year as a graduate student at The Ohio State University.
My research in the Turro Group is currently focused on the development of an MRI imaging agent involving Gadolinium containing Cyclen chains. Functionalization of the Cyclen allows the attachment of photoreactive dyes and cancer sensitive antibodies. This allows multimodal imaging, utilizing both MRI and Luminescence Assays in cancer detection.
top
Alycia Palmer: email
I studied chemistry and math at Heidelberg University and graduated with a B.S. in 2009. During that time, I had an internship at IBM in San Jose where I synthesized inorganic nanoparticles for photovoltaic devices. Now in Dr. Turro's group, I continue to study photophysical processes but with applications to medical imaging and cancer drugs. I am beginning a project to improve the medical imaging dye IR-1061 to target tumor cells.
I am also working with Dr. Sheldon Shore to test decaborane derivatives for use as radioimmunotherapy agents. The cages have several sites available to bind radioactive iodine and can be linked to antibodies which target tumor cells. We have reason to believe that the iodine will be bound tightly to the boron vertices, and this is important to prevent thyroid enzymes from harvesting the radioactive iodine.
top
Ivan Cussianovich: email
Morbi eu mi justo, vitae aliquam neque. Donec tincidunt, lacus ac commodo porta, urna mi suscipit ipsum, consequat iaculis risus urna et metus. Integer interdum ultrices rutrum. Nam eget nulla id tellus aliquet ultricies. Nullam eu enim a dolor adipiscing faucibus quis vitae nunc. Donec vitae sem urna, nec mattis quam. Nunc accumsan mattis sapien, sit amet egestas elit imperdiet eu. Fusce nisi ligula, vehicula vitae semper sed, tincidunt sed turpis. Ut blandit accumsan convallis. Vestibulum id ligula ut magna ultrices ultricies ac eu mauris
top
Bryan Albani: email
Morbi eu mi justo, vitae aliquam neque. Donec tincidunt, lacus ac commodo porta, urna mi suscipit ipsum, consequat iaculis risus urna et metus. Integer interdum ultrices rutrum. Nam eget nulla id tellus aliquet ultricies. Nullam eu enim a dolor adipiscing faucibus quis vitae nunc. Donec vitae sem urna, nec mattis quam. Nunc accumsan mattis sapien, sit amet egestas elit imperdiet eu. Fusce nisi ligula, vehicula vitae semper sed, tincidunt sed turpis. Ut blandit accumsan convallis. Vestibulum id ligula ut magna ultrices ultricies ac eu mauris